Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  05/17/2011
 
Trade Name:  Faslodex Injection
 
Generic Name or Proper Name (*):  fulvestrant
 
Indications Studied:  Use in girls with progressive precocious puberty associated with McCune-Albright Syndrome
 
Label Changes Summary:  Efficacy has not been demonstrated in girls with McCune-Albright Syndrome associated with progressive precocious pubertyInformation on dosing, adverse reactions, pharmacokinetics and clinical trial
 
Product Labeling:  Labeling  Opens a new window
 
BPCA(B):  B
 
Sponsor:  AstraZeneca
 
Pediatric Exclusivity Granted Date:  02/01/2011
 
NNPS:  FALSE'
 
Therapeutic Category:  Estrogen lowering agent
 
-
-